News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
19,067 Results
Type
Article (1526)
Company Profile (6)
Press Release (17535)
Section
Business (4688)
Career Advice (11)
Deals (821)
Drug Delivery (3)
Drug Development (2692)
Employer Resources (4)
FDA (905)
Job Trends (499)
News (8887)
Policy (818)
Tag
Academia (112)
Alliances (1022)
ALS (21)
Alzheimer's disease (114)
Approvals (903)
Artificial intelligence (4)
Bankruptcy (8)
Best Places to Work (440)
Biotechnology (7)
Breast cancer (3)
Cancer (23)
Career advice (11)
Cell therapy (14)
Clinical research (2013)
Collaboration (15)
Compensation (12)
COVID-19 (66)
Data (51)
Diagnostics (86)
Drug discovery (3)
Drug pricing (3)
Earnings (1882)
Employer resources (4)
Events (2425)
Executive appointments (15)
FDA (934)
Funding (21)
Gene therapy (21)
GLP-1 (19)
Government (114)
Healthcare (555)
Huntington's disease (4)
Infectious disease (68)
IPO (365)
Job creations (65)
Job search strategy (10)
Layoffs (17)
Legal (149)
Manufacturing (5)
Medical device (1136)
Medtech (1137)
Mergers & acquisitions (467)
Metabolic disorders (6)
Multiple sclerosis (10)
Neurodegenerative disease (9)
Neuroscience (167)
NextGen: Class of 2025 (226)
Non-profit (163)
Northern California (47)
Obesity (5)
Opinion (12)
Pain (7)
Parkinson's disease (7)
Patents (3)
People (1394)
Phase I (704)
Phase II (968)
Phase III (668)
Pipeline (22)
Postmarket research (99)
Preclinical (284)
Rare diseases (17)
Real estate (127)
Regulatory (600)
Reports (3)
Research institute (99)
Series A (6)
Series B (4)
Southern California (53)
Startups (127)
United States (476)
Vaccines (12)
Date
Today (3)
Last 7 days (21)
Last 30 days (78)
Last 365 days (970)
2025 (158)
2024 (1022)
2023 (1149)
2022 (1833)
2021 (1837)
2020 (1559)
2019 (1369)
2018 (1084)
2017 (1099)
2016 (1074)
2015 (1134)
2014 (793)
2013 (699)
2012 (673)
2011 (626)
2010 (531)
Location
Africa (8)
Asia (755)
Australia (147)
California (127)
Canada (50)
China (3)
Colorado (5)
Connecticut (7)
Europe (1969)
Florida (14)
Illinois (13)
Indiana (3)
Maryland (10)
Massachusetts (114)
Michigan (6)
Minnesota (20)
Montana (11)
New Jersey (31)
New York (15)
North Carolina (8)
Northern California (47)
Ohio (5)
Pennsylvania (26)
South America (19)
Southern California (53)
Texas (45)
Utah (3)
Virginia (4)
19,067 Results for "spinal singularity".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Roche’s Evrysdi Becomes First Pill Cleared for Spinal Muscular Atrophy
Evrysdi is the first, and so far only, noninvasive disease-modifying treatment for spinal muscular atrophy.
February 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Singular Genomics Announces Closing of Acquisition by Deerfield Management
February 24, 2025
·
4 min read
Neurodegenerative disease
Scholar Rock’s Shares Soar 300% After Phase III Win in Spinal Muscular Atrophy
With Monday’s data from SAPPHIRE, Scholar Rock is building toward regulatory submissions for apitegromab in spinal muscular atrophy in the first quarter of 2025.
October 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
February 12, 2025
·
11 min read
Press Releases
FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy
February 13, 2025
·
4 min read
Press Releases
MEDCURA FORMS WORLD-CLASS SPINAL SURGERY ADVISORY BOARD
January 16, 2025
·
4 min read
Press Releases
icotec Announces FDA clearance for Spinal Infection Indication with BlackArmor® Implants
January 14, 2025
·
3 min read
Biotech Beach
Singular Genomics Announces 1-for-30 Reverse Stock Split
Singular Genomics Systems, Inc. announced that on June 26, 2024, effective at 12:01 a.m. Eastern Time, it will effectuate a 1-for-30 reverse split of its common stock.
June 21, 2024
·
5 min read
Press Releases
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
February 13, 2025
·
7 min read
Press Releases
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
February 13, 2025
·
9 min read
1 of 1,907
Next
